These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Excessive L-thyroxine therapy decreases femoral bone mineral densities in the male rat: effect of hypogonadism and calcitonin. Ongphiphadhanakul B, Alex S, Braverman LE, Baran DT. J Bone Miner Res; 1992 Oct; 7(10):1227-31. PubMed ID: 1456090 [Abstract] [Full Text] [Related]
28. Timing of growth hormone treatment affects trabecular bone microarchitecture and mineralization in growth hormone deficient mice. Kristensen E, Hallgrímsson B, Morck DW, Boyd SK. Bone; 2010 Aug; 47(2):295-300. PubMed ID: 20399917 [Abstract] [Full Text] [Related]
29. A short course of recombinant human growth hormone treatment stimulates osteoblasts and activates bone remodeling in normal human volunteers. Brixen K, Nielsen HK, Mosekilde L, Flyvbjerg A. J Bone Miner Res; 1990 Jun; 5(6):609-18. PubMed ID: 2382586 [Abstract] [Full Text] [Related]
30. Combined treatment with GH and IGF-I: additive effect on cortical bone mass but not on linear bone growth in female rats. Sundström K, Cedervall T, Ohlsson C, Camacho-Hübner C, Sävendahl L. Endocrinology; 2014 Dec; 155(12):4798-807. PubMed ID: 25243853 [Abstract] [Full Text] [Related]
31. [The effect of growth hormone replacement therapy on markers of bone formation and bone mineral density in elderly men]. Kozakowski J, Papierska L, Krassowski J, Zgliczyński S. Pol Arch Med Wewn; 1998 Oct; 100(4):306-12. PubMed ID: 10335039 [Abstract] [Full Text] [Related]
32. Effects of exogenous growth hormone on bone mineralization and remodeling and on plasma calcitriol in intact pigs. Denis I, Zerath E, Pointillart A. Bone; 1994 Oct; 15(4):419-24. PubMed ID: 7917581 [Abstract] [Full Text] [Related]
33. [Effect of growth hormone combined with Radix Dipsaci on the body growth and the bone metabolism of hypophysectomized rats]. Liu YK, Zhang ZX, Zhang Q. Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Dec; 31(12):1690-4. PubMed ID: 22384560 [Abstract] [Full Text] [Related]
34. Effect of growth hormone (GH) treatment on bone in postpubertal GH-deficient patients: a 2-year randomized, controlled, dose-ranging study. Shalet SM, Shavrikova E, Cromer M, Child CJ, Keller E, Zapletalová J, Moshang T, Blum WF, Chipman JJ, Quigley CA, Attanasio AF. J Clin Endocrinol Metab; 2003 Sep; 88(9):4124-9. PubMed ID: 12970274 [Abstract] [Full Text] [Related]
35. Cortical bone growth and maturational changes in dwarf rats induced by recombinant human growth hormone. Martinez DA, Orth MW, Carr KE, Vanderby R, Vailas AC. Am J Physiol; 1996 Jan; 270(1 Pt 1):E51-9. PubMed ID: 8772473 [Abstract] [Full Text] [Related]
36. Estrogen agonist (zeranol) treatment in a castrated male lamb model: effects on growth and bone mineral accretion. Chanetsa F, Hillman LS, Thomas MG, Keisler DH. J Bone Miner Res; 2000 Jul; 15(7):1361-7. PubMed ID: 10893685 [Abstract] [Full Text] [Related]
38. Preservation of bone mass in hypogonadal female monkeys with recombinant human growth hormone administration. Mann DR, Rudman CG, Akinbami MA, Gould KG. J Clin Endocrinol Metab; 1992 Jun; 74(6):1263-9. PubMed ID: 1592869 [Abstract] [Full Text] [Related]
40. Effect of parathyroid hormone-related peptide supplementation of soy protein formulas in the neonatal pig model. Hillman LS, Forte LR, Veum T, Ru Y, Howard B, Rowe A, Hillman HW. J Bone Miner Res; 1994 Jul; 9(7):1047-52. PubMed ID: 7942151 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]